What is the dynamic synergy between pioneering science and transformative industry developments? Join us in this episode of BioTalk with Rich Bendis for a thought-provoking conversation about the work of Blackbird Laboratories. Our guest, Matt Tremblay, Ph.D., Chief Executive Officer of Blackbird Laboratories, sheds light on their role in fostering innovation within the vibrant BioHealth community of Baltimore and the wider BioHealth Capital Region.
Blackbird Laboratories recently launched with a significant $100 million founding grant from The Stephen and Renee Bisciotti Foundation. This significant investment aims to bridge the gap between academic research and industry innovation, catalyzing the development of innovative companies, groundbreaking technologies, and a thriving entrepreneurial ecosystem in Baltimore, Maryland. They provide crucial support, including capital, program management, and strategic scientific and business insights, to drive the growth of the BioHealth industry. Their team of seasoned life sciences professionals operates on a value-driven model, committed to reducing the risk of groundbreaking technology for commercialization, attracting crucial investments, nurturing start-ups, and cultivating meaningful public-private partnerships. Their vision is grounded in promoting a thriving ecosystem in Baltimore that will contribute significantly to the growth of the BioHealth sector in the region.
In this engaging episode, we’ll delve into a diverse range of topics:
Don’t miss this insightful episode as we discuss the promising future of BioHealth with Blackbird Laboratories leading the way. Tune in now and become an integral part of the conversation shaping the BioHealth industry’s destiny.
Doug Falk, Vita Therapeutics (EP.111)
Dave Saunders, Galen Robotics (EP.110)
Mike Gill, Maryland Commerce Secretary (EP.109)
Ray Blanchard, Qiagen (EP.108)
Darryll J. Pines, University of Maryland (EP.107)
Ken Malone, Early Charm Ventures (EP.106)
Ron Kurz, Canon Virginia, Inc. (EP.105)
Marty Rosendale, Maryland Tech Council (EP.104)
Ron Piervincenzi, Ph.D., United States Pharmacopeia (EP.103)
Geoffrey Lynn, Vaccitech (EP.101)
Bill Enright, Vaccitech (EP.101)
Ellington West, Sonavi Labs (EP.100)
Amritha Jaishankar, PhD, Maryland Stem Cell Research Fund (MSCRF) (EP.99)
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)
Seth Toback, Novavax and Divya Chadha Manek, National Institute for Health Research (NIHR) (EP.97)
From the 7th Annual BioHealth Capital Region Forum - Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP) (EP.96)
From the 7th Annual BioHealth Capital Region Forum - Dr. Anthony Fauci (EP.95)
Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)
Lily Qi, Maryland State Delegate
Reverse BioTalk – Jeff Galvin, CEO of American Gene Technologies Interviews Rich Bendis, CEO and President of BioHealth Innovation, Inc.
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money